The landscape of Multiple Myeloma Treatment is undergoing a transformative shift with the emergence of bispecific antibodies. These innovative therapies offer new hope for patients with relapsed or refractory multiple myeloma, providing an effective option when traditional treatments fail. As the field of oncology continues to evolve, bispecific antibodies are setting a new standard for...